INTRODUCTION
G protein-coupled receptors (GPCRs) enable eukaryotic cells to respond to a large variety of extracellular signals including hormones, odorants, and light (1) . One of the best studied GPCR-initiated signaling pathways is the visual cascade in retinal rods (2) . It is initiated by the absorption of a photon in the visual receptor, rhodopsin, and subsequent isomerization of the 11-cis-retinal, which is covalently attached to Lys 296 in the seventh transmembrane helix of the receptor. Via a series of transient intermediates, rhodopsin converts in milliseconds into metarhodopsin II (MII), the form of rhodopsin that interacts with the heterotrimeric G-protein transducin (G t ). This interaction initiates the intermolecular transduction of the light signal by catalyzing GDP/GTP exchange in the nucleotide binding site of the G protein and, in turn activates the G protein-coupled effector, a cyclic GMP-specific phosphodiesterase (PDE). Hydrolysis of cGMP leads to the closure of plasma membrane cation channels and hyperpolarization of the membrane (3) .
The deactivation of rhodopsin starts with the binding of a rhodopsin kinase to photoactivated rhodopsin (4) . Rapid phosphorylation of the receptor at C-terminal sites (5) increases its affinity for arrestin (6) . Biochemical (7) and electrophysiological (8) evidence has been accumulated that visual arrestins deactivate the visual cascade by direct competition with the G-protein for the active receptor. However, the mechanism of interaction underlying the quench is still not well understood.
UV-Vis spectroscopy has shown that, to bind arrestin, the light activation of rhodopsin must proceed up to the MII conformation, in which the Schiff base bond of the retinal to the apoprotein is still intact but deprotonated (9) . Only after MII formation and phosphorylation of the receptor, arrestin interacts rapidly with the receptor. Although the catalytic activity of MII towards the G-protein is quenched, arrestin binding (and phosphorylation) stabilizes MII at the expense of its tautomeric forms (see Ref. (6) and citations therein). A conformational difference in arrestin and/or rhodopsin on interaction was early suggested by the unusually high apparent activation energy of rhodopsin-arrestin interaction (9) . Later studies have indeed shown that binding of arrestin to the active receptor protects arrestin against limited proteolysis (10) and Lysine acetylation (11) , suggesting that arrestin bound rhodopsin adopts a conformation (A b ) which is different from that of free, inactive (A i ) arrestin.
Investigations employing protein engineering (12, 13) and phosphorylated peptides (14) have provided evidence for a sequential mechanism, in which the contact of the negatively charged regions of phosphorylated rhodopsin (P-site) with the cationic region acts as a trigger, switching arrestin into its active conformation and allowing interaction with the rhodopsin binding sites exposed on photoactivation.
A highly cationic region near the center of the arrestin sequence, beginning with residue 163, was proposed to mediate the interaction with the P-site, thus enabling the contact with other interaction sites exposed in the MII state (M-sites) (10) . Arg 175 (within the putative recognition site for the phosphorylated site(s) on rhodopsin) was identified as a key residue for arrestin to distinguish between phosphorylated and unphosphorylated rhodopsin (15, 16) . Recent structural assignments (17, 18) have now identified this residue as part of a "polar core" (18), a central region in arrestin, localized between the N-and C-terminal domains of the molecule. It may act as a fulcrum for the conversion of inactive A i to active A b (19).
The conformational switch is additionally controlled by arrestin´s C-terminus (20, 21) . When it is lacking, as in a splice variant of arrestin, p 44 , the short arrestin binds both phosphorylated and nonphosphorylated forms of MII and even Cterminally truncated rhodopsin (22, 23) . Protein engineering (24) and spectroscopic data (25) residues interact with positively charged residues on the N-terminal region, and that this interaction is broken upon binding to phosphorylated MII.
In the present study we attempt to identify specific sites of arrestin that become exposed by the conformational switch, leading to their interaction with the respective receptor sites in the MII conformation. The technique applied is based on the spectrophotometric MII stabilization assay (9) and on competition with peptides derived from arrestin and G t . Peptide competition has already been applied in previous studies, to map regions of interaction in the receptor-arrestin complex. Studies with peptides from rhodopsin's surface exposed sequences suggested a role of different loop structures in the interaction (26) . Regarding the interactive domains in arrestin,
Hargrave and coworkers have employed a library of peptides covering the entire sequence. Based on phage-display and PDE activation data, they localized one of the principal regions of interaction within residues 109-130 (27) and found indications of additional sites in their data.
We will indeed provide evidence that more than one (namely three) regions in the arrestin molecule are involved in receptor binding. Employing the sensitive MII stabilization assay, and peptide competition not only with arrestin but also with G t and G t derived peptides, we can measure with unprecedented specificity. Based on the data from three sets of overlapping synthetic 10 to 30-residue peptides, spanning the arrestin sequence, we propose a model locating the receptor binding regions of arrestin in each of the two domains of the molecule. 
Isolation of Bovine Rod Outer Segments (ROS)
. ROS were purified from fresh, dark-adapted bovine retinas obtained from a local slaughterhouse using the discontinuous sucrose gradient method described by Papermaster (28) . Retinas were dissected, and ROS were isolated, under dim red illumination. All subsequent procedures were performed at 0-5 °C and the ROS were stored frozen at -80°C until use.
Preparation of Washed Membranes. Rhodopsin was prepared by removing the soluble and membrane-associated proteins from the disc membrane by repetitive washes with a low ionic strength buffer (29) . All purification steps were performed under dim red illumination and the membrane suspension was stored at -80°C until use.
Preparation of Phosphorylated Opsin. Phosphorylated opsin was prepared from washed disc membranes as described previously by Wilden and Kühn (30) . To remove retinaloxime from the membrane-bound phosphorylated opsin the membranes were treated with urea and fatty acid-free bovine serum albumin (31) . An average stoichiometry of ~ 1.5 phosphates per opsin was determined using radioactive Preparation of arrestin. Arrestin was purified from frozen dark-adapted bovine retinas as described by Heck et al. (33) .
Preparation of transducin.
Transducin was isolated from frozen dark-adapted bovine retinas according to Heck and Hofmann (34) .
Peptide synthesis, purification and characterization. Peptides were synthesized using the Fmoc (N-(9-fluorenyl)methoxycarbonyl) strategy with HBTU activation ( Fastmoc -0.1 mmol small-scale cycles) on an ABI Model 433A peptide synthesizer. The peptides were purified by reverse phase high performance liquid chromatography (HPLC), lyophilized and stored at -20°C. Immediately before the experiments, the peptides were dissolved in deionized water to obtain stock solutions of 2 mM and pH was adjusted to 7.0 with NaOH. Farnesylation of G t -derived peptides was carried out as described (35) .
Protein Determinations. The concentration of rhodopsin and phosphorylated rhodopsin was determined spectrophotometrically at 498 nm as previously described (23) . Purified arrestin was determined spectrophotometrically at 278 nm, assuming a molar absorption coefficient of E 0.1% = 0.638 (36) and a molecular mass of 45,300 Da.
Purified transducin (G t ) concentration was determined using the Bradford method (37).
UV/Vis Spectroscopy. Formation of the photoproduct metarhodopsin II (MII, max = 380 nm) was assayed using the two-wavelength technique (9, 38) . This wavelength spectrophotometer (UV 300, Shimadzu Scientific Instruments, Inc., Japan; 2 nm slit) is equipped with thermostated cuvettes (2 mm path), temperature regulation (Circulator G/D8, Haake GmbH, Karlsruhe, Germany), and a green photoflash (filtered to 500 ± 20 nm).
When photolysed rhodopsin in its native disc membrane is cooled to temperatures at which the equilibrium is on the MI side (below 5°C and pH 8.0) (39), any specific binding of protein or peptide to MII causes enhanced formation of MII (extra-MII).
Extra MII provides a kinetic and stoichiometric measure for the complex between photoactivated rhodopsin and the interactive polypeptide (40) . and apparent Hill coefficients (n), are listed in Table I . High values of n may be due to a tendency of the peptide to aggregate and do therefore not enter the calculation in the Appendix.
Transducin forms enhanced MII complexes with photoactivated nonphosphorylated rhodopsin. It is further known that arrestin inhibits the activity of photoactivated rhodopsin towards the G-protein (7) . We therefore investigated whether arrestin peptides can inhibit the transducin dependent formation of extra MII.
As shown in Fig. 2B , the two peptides that compete with arrestin also compete with G t with similar relative efficiency, providing a control for direct interaction of the peptides with rhodopsin (see Discussion).
Arrestin Peptides Compete with G t γ-farnesyl but not G t α C-terminal
Peptides. The question was whether arrestin peptides interfere with G t -derived peptides in their interaction with photoexcited rhodopsin. One may expect that this can be tested by direct competition, because C-terminal peptides from G t stabilize the MII state like the holoprotein (41, 42) , but arrestin peptides do not (see above, Fig.   2 ). Fig. 3 shows for two examples that arrestin peptides can indeed competitively inhibit the formation of extra MII induced by G t -derived peptides. The effect is specifically seen with the G t -farnesyl peptide, indicating an overlap of the respective binding sites at rhodopsin. No such inhibition was measured for the interaction with the G t α C-terminal peptide (native and high affinity analog).
As is seen in Fig. 4 , almost all the peptides that compete with arrestin do so with G t and the G t γ C-terminal peptide as well. An exception is the region near the N- The regions of peptide competition mark possible candidates for interaction sites with active phosphorylated rhodopsin. However, it is clear that peptide competition by itself is not specific. For example, the peptides could affect sites of intramolecular interaction, involved in conversions necessary to reach the active conformation. Since we know that such a conformational switch in arrestin occurs (see below), this latter possibility is quite realistic. A criterion was found in the comparison of arrestin with G t and G t peptides. The data in Fig. 4 have shown that most of the peptides that compete with arrestin, also compete with G t and the farnesylated G t γ C-terminal peptide. The loss of competition between position 65 and 83 is also reproduced. Because intramolecular switches in arrestin and G t are unlikely to involve homologous domains, this similarity can be taken as a strong evidence for binding of arrestin and G t or its γ-farnesyl peptide to rhodopsin´s surface with sufficient overlap (Fig. 5 ).
Multiple interaction sites.
Our approach is similar to the one taken by Smith arrestin that bind to rhodopsin. Using a phage-display technique of arrestin fragments and G t binding and activation assays, these authors identified a stretch comprising residues 109-130 as a site involved in the interaction with rhodopsin. Because of the low affinity of this region (IC 50 of 1.1 mM) it was suggested that this portion of arrestin may be only one of several binding sites for rhodopsin (27) . In the present study, using the fundamentally different extra MII assay, we find indeed peptide competition with similar IC 50 in this region (Table I) (Table I , Fig. 4 ). The reason for detection of these sites by our assay is probably the capturing of the interactions as they occur within seconds after the activating light flash.
The region near the N-terminus (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) shows strong competition but is only conserved in the visual arrestins, or S-antigens (43) . This is also the region where the only significant difference between arrestin and G t competition arises. Possible explanations include a role both in arrestin-rhodopsin interaction and in the switch mechanism (see below), in agreement with the conclusions drawn from mutational studies (19). In any case, the lack of conservation in this region would argue for a specific role in visual arrestins.
Conformational switch. S-antigen, and presumably all arrestins share with the G-proteins a conformational switch, operated by the contact with the active receptor (3, 9, 10, 12, 13) . Based on structural assignments, Sigler and coworkers (18, 19) have specified a trigger mechanism of the conformational switch, in which the where two distant sites (the C-termini of the αand the γ-subunits, which are 45 Å apart) are involved in the signal transfer (41) . For arrestin and G t (see Refs. (23) and (39) , respectively), the simultaneous binding of two receptors at one molecule is unlikely because the titration of the complexes yields 1:1 ratios.
In spite of the similarity in conformational interlocking, arrestin and G t appear to use different mechanisms of microscopic (i.e. site to site) recognition. For the Gprotein, it is known that the G t α and farnesylated G t γ C-terminal sequences have the capacity to recognize the MII species and to distinguish it from the other intermediates (41, 44 The experiments were otherwise performed as in Fig. 1 . 
APPENDIX
The following reaction scheme was used to determine the K D3 values: (7) The IC 50 value represent the arrestin peptide concentration where the extra MII signal is inhibited to 50%.
Note: Peptide binding to R or R* led to very similar K D3 values (errors < 1%). 
